PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Go back to PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
(NASDAQ: PYPD) Delayed: 3.90 -0.34 (8.02%)
Previous Close $4.24    52 Week High
Open $4.23    52 Week Low
Day High $4.30    P/E N/A 
Day Low $3.88    EPS
Volume 286,472